Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors
US8937064B2 · kind B2 · utility
1Cited by
7References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2010 |
| Grant date | Jan 20, 2015 |
| Priority date | — |
| Expiry date | Jun 17, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) useful as selective inhibitors of JAK2 kinase. The invention also provides pharmaceutical acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various diseases, conditions or disorders. The invention also provides processes for preparing the compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.